Tickerplace logo

Tickerplace

Tekla Life Sciences Investors logo

HQLTekla Life Sciences Investors

HQL Stock Price, Valuation & Chart | Tekla Life Sciences Investors

Compare
$20.980+0.11 (+0.53%)

At close · 02 Sept 2026, 08:00 pm

Sector: Financial ServicesIndustry: Asset ManagementHQL intrinsic valueHQL calculated fair value vs price
OverviewFinancialsDividendsRatios

HQL Historical price chart

HQL Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization637.96M
PE Ratio-50.44
EPS-0.42
Trading Volume141.13K
Today's High/Low21.43/20.79
Dividend Yield10.68
52 Week High/Low22.67/13.88
Shares Outstanding30.41M
HQL Financial Statement
HQL Analyst ratings
HQL Analysis & performance metrics

HQL Company profile

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the…

HQL Management team

Management
Peter Branner
Chief Investment Officer
Daniel R. Omstead M.S, Ph.D.
Principal Executive Officer, President and Trustee
Total 2 executives

HQL Frequently asked questions

What is Tekla Life Sciences Investors (HQL) Stock Price?

Current stock price of Tekla Life Sciences Investors (HQL) stock is $20.980. The stock price is +0.53% higher in the session. The intraday range can be seen from this page. Volume of Tekla Life Sciences Investors (HQL) stock is 141.13K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Tekla Life Sciences Investors (HQL) stock price going up or down today?

The stock price of Tekla Life Sciences Investors (HQL) can change with earnings, company news, and overall market sentiment. Tekla Life Sciences Investors operates in the Financial Services / Asset Management market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Tekla Life Sciences Investors stock expensive at its current price?

Whether Tekla Life Sciences Investors looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for HQL on this page is -50.44. EPS on this page is -0.42. Compare those figures with peers and growth expectations before deciding if the current Tekla Life Sciences Investors price is justified.

How has the stock price of Tekla Life Sciences Investors (HQL) performed historically?

Historical performance for Tekla Life Sciences Investors (HQL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how HQL reacted to past earnings and market events.

Should I buy Tekla Life Sciences Investors (HQL) stock, at this price?

Buying Tekla Life Sciences Investors (HQL) depends on your risk tolerance, time horizon, and portfolio needs. As a Financial Services name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.